Use of a Monoclonal Antibody in an Enzyme Immunoassay for the Detection of Entamoeba histolytica in Fecal Specimens

View More View Less
  • Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205
Restricted access

An indirect enzyme-linked immunosorbent assay (ELISA) was developed for the detection of Entamoeba histolytica in human feces, using both a monoclonal antibody and rabbit antisera. It detected from less than 1 to 57 trophozoites of 6 E. histolytica strains. Stool specimens were positive by ELISA in 18 of 22 (82%) patients with E. histolytica and in 3 of 186 (2%) of patients without demonstrable E. histolytica in their stools. The latter included one from a child living near an asymptomatic cyst carrier and another from a traveler with giardiasis who had recently taken antibiotics. One hundred eight of 183 microscopy- and ELISA-negative specimens contained other parasites including Giardia (49 specimens), Endolimax nana (24), Entamoeba coli (21), Iodamoeba butschlii (2), and Entamoeba hartmanni (1). This ELISA for E. histolytica is a simple, sensitive and specific diagnostic tool.